Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD
Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD)
Sponsor: Baylor College of Medicine
A NA clinical study on Argininosuccinate Lyase Deficiency and Argininosuccinic Aciduria, this trial is completed. The trial is conducted by Baylor College of Medicine and has accumulated 11 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2022 — Mar 2023 [monthly]
Recruiting NA
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2019 — Sep 2020 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2019 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
-
Mar 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
- Neogenis Laboratories
- Rare Diseases Clinical Research Network
For direct contact, visit the study record on ClinicalTrials.gov .